WM
Waheed Mave Abdul
About Waheed Mave Abdul
Data last updated:
Waheed Mave Abdul is a Director at Telmed Pharmaceutical Private Limited (since 2023) and Director at Mewone Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma and Paper. The largest current company by reported revenue is Telmed Pharmaceutical Private Limited at ₹34.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Telmed Pharmaceutical Private Limited U24304MP2020PTC051969 | Director | 30 Jun 2023 | 2020 | ₹34.3 Lakh (FY 2025) | Active |
| Mewone Pharmaceuticals Private Limited U21002DL2023PTC422855 | Director | 20 Nov 2023 | 2023 | Active |
Board colleagues of Waheed Mave Abdul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohammad Imran Mew | 10181937 | Telmed Pharmaceutical Private Limited , Mewone Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Waheed Mave Abdul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Waheed Mave Abdul
Waheed Mave Abdul currently holds 2 directorships: Telmed Pharmaceutical Private Limited (Director, since 30 Jun 2023, revenue ₹34.3 Lakh (FY 2025)); Mewone Pharmaceuticals Private Limited (Director, since 20 Nov 2023).
Waheed Mave Abdul was first appointed on 30 Jun 2023 as Director at Telmed Pharmaceutical Private Limited.
The current boards of Waheed Mave Abdul's companies include Mohammad Imran Mew (Telmed Pharmaceutical Private Limited).